Merck & Co. said its surprise decision Thursday to withdraw thearthritis drug Vioxx -- used by about 2 million people worldwide --was driven by recent evidence that the drug's adverse side effectsoutweighed any potential benefits.
Vioxx andother Cox-2 inhibitors like Celebrex had been promoted as wonderdrugs, since they provided pain relief to arthritis sufferers withoutcausing stomach problems, but now Vioxx is off the market and theothers are under a cloud.
The announcementcomes just two weeks after Merck pulled its painkiller, Vioxx, whichis in the same class of drugs as Bextra, from the market because astudy showed that the risk of
